Clinical Trials: Intracerebral Cell Therapy in Stroke Patients
暂无分享,去创建一个
[1] M. Walker,et al. Granulocyte-Colony Stimulating Factor for Mobilizing Bone Marrow Stem Cells in Subacute Stroke: The Stem Cell Trial of Recovery Enhancement After Stroke 2 Randomized Controlled Trial , 2012, Stroke.
[2] K. Muir,et al. Stem cell therapy in stroke: Designing clinical trials , 2011, Neurochemistry International.
[3] J. Grotta,et al. Intravenous autologous bone marrow mononuclear cells for ischemic stroke , 2011, Annals of neurology.
[4] Takuya Matsunaga,et al. Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. , 2011, Brain : a journal of neurology.
[5] Michael Chopp,et al. Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II , 2011, Stroke.
[6] D. Rosenbaum,et al. Cell therapy for stroke , 2004, NeuroRX.
[7] O. Bang,et al. A Long‐Term Follow‐Up Study of Intravenous Autologous Mesenchymal Stem Cell Transplantation in Patients With Ischemic Stroke , 2010, Stem cells.
[8] Yu Luo. Cell-based therapy for stroke , 2010, Journal of Neural Transmission.
[9] T. Yasuhara,et al. Notch-induced rat and human bone marrow stromal cell grafts reduce ischemic cell loss and ameliorate behavioral deficits in chronic stroke animals. , 2009, Stem cells and development.
[10] D. Corbett,et al. Transplantation of human embryonic stem cell‐derived neural precursor cells and enriched environment after cortical stroke in rats: cell survival and functional recovery , 2009, The European journal of neuroscience.
[11] M. L. Bringas-Vega,et al. Autologous bone marrow stem cell neurotransplantation in stroke patients. An open study. , 2009, Restorative neurology and neuroscience.
[12] N. Bresolin,et al. Stem cell therapy in stroke , 2009, Cellular and Molecular Life Sciences.
[13] R. Guzman,et al. Intravascular cell replacement therapy for stroke. , 2008, Neurosurgical focus.
[14] J. Sinden,et al. Development of a human neural stem cell line for use in recovery from disability after stroke. , 2008, Frontiers in bioscience : a journal and virtual library.
[15] A. Blanco,et al. Autologous bone-marrow mononuclear cell implantation in patients with severe lower limb ischaemia: a comparison of using blood cell separator and Ficoll density gradient centrifugation. , 2007, Atherosclerosis.
[16] D. Hess,et al. Transplantation of Bone Marrow-Derived Stem Cells: A Promising Therapy for Stroke , 2007, Cell transplantation.
[17] Raphael Guzman,et al. Cell Transplantation Therapy for Stroke , 2007, Stroke.
[18] Yi Li,et al. Therapeutic Benefit of Bone Marrow Stromal Cells Administered 1 Month after Stroke , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[19] I. Black,et al. Marrow Stromal Cells Transplanted to the Adult Brain Are Rejected by an Inflammatory Response and Transfer Donor Labels to Host Neurons and Glia , 2006, Stem cells.
[20] Anthony Atala,et al. Methods Of Tissue Engineering , 2006 .
[21] Hung Li,et al. Homing genes, cell therapy and stroke. , 2006, Frontiers in bioscience : a journal and virtual library.
[22] P. Stieg,et al. Neurotransplantation of Fetal Porcine Cells in Patients with Basal Ganglia Infarcts: A Preliminary Safety and Feasibility Study , 2005, Cerebrovascular Diseases.
[23] Ross Zafonte,et al. Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. , 2005, Journal of neurosurgery.
[24] Oh Young Bang,et al. Autologous mesenchymal stem cell transplantation in stroke patients , 2005, Annals of neurology.
[25] K. Jin,et al. Comparison of ischemia-directed migration of neural precursor cells after intrastriatal, intraventricular, or intravenous transplantation in the rat , 2005, Neurobiology of Disease.
[26] D. Kondziolka,et al. Changes in cognitive function after neuronal cell transplantation for basal ganglia stroke , 2004, Neurology.
[27] D. Kondziolka,et al. Evaluation of Surgical Techniques for Neuronal Cell Transplantation Used in Patients with Stroke , 2004, Cell transplantation.
[28] H. Naritomi,et al. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. , 2004, The Journal of clinical investigation.
[29] Mari Dezawa,et al. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. , 2004, The Journal of clinical investigation.
[30] O. Isacson,et al. Increased proportion of acetylcholinesterase-rich zones and improved morphological integration in host striatum of fetal grafts derived from the lateral but not the medial ganglionic eminence , 2004, Experimental Brain Research.
[31] Yi Li,et al. Treatment of neural injury with marrow stromal cells , 2002, The Lancet Neurology.
[32] M. Chopp,et al. Intravenous Administration of Human Umbilical Cord Blood Reduces Behavioral Deficits After Stroke in Rats , 2001, Stroke.
[33] D. Kondziolka,et al. Serial [18F]Fluorodeoxyglucose Positron Emission Tomography after Human Neuronal Implantation for Stroke , 2001, Neurosurgery.
[34] M. Chopp,et al. Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats , 2001, Journal of the Neurological Sciences.
[35] D. Kondziolka,et al. Transplantation of cultured human neuronal cells for patients with stroke , 2000, Neurology.
[36] D. Kondziolka,et al. Restorative neurosurgery: opportunities for restoration of function in acquired, degenerative, and idiopathic neurological diseases. , 1999, Neurosurgery.
[37] P. Sanberg,et al. Neural transplantation of human neuroteratocarcinoma (hNT) neurons into ischemic rats. A quantitative dose–response analysis of cell survival and behavioral recovery , 1999, Neuroscience.
[38] J. Trojanowski,et al. Transplantation of Cryopreserved Human Embryonal Carcinoma-Derived Neurons (NT2N Cells) Promotes Functional Recovery in Ischemic Rats , 1998, Experimental Neurology.
[39] J. Trojanowski,et al. Transfectable and Transplantable Postmitotic Human Neurons: A Potential “Platform” for Gene Therapy of Nervous System Diseases , 1997, Experimental Neurology.
[40] H. Nishino,et al. Neural Transplantation as an Experimental Treatment Modality for Cerebral Ischemia , 1997, Neuroscience & Biobehavioral Reviews.
[41] T. Deacon,et al. Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibres , 1995, Nature Medicine.
[42] J. Trojanowski,et al. Transplanted human neurons derived from a teratocarcinoma cell line (NTera‐2) mature, integrate, and survive for over 1 year in the nude mouse brain , 1995, The Journal of comparative neurology.
[43] C. Borlongan,et al. Elevated body swing test: a new behavioral parameter for rats with 6- hydroxydopamine-induced hemiparkinsonism , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[44] T. Deacon,et al. A novel mode of immunoprotection of neural xenotransplants: Masking of donor major histocompatibility complex class I enhances transplant survival in the central nervous system , 1995, Neuroscience.
[45] O. Isacson,et al. Cytoarchitectonic Development, Axon-Glia Relationships, and Long Distance Axon Growth of Porcine Striatal Xenografts in Rats , 1994, Experimental Neurology.
[46] B. Johansson,et al. Functional Recovery after Brain Infarction: Plasticity and Neural Transplantation , 1994, Brain pathology.
[47] Virginia M. Y. Lee,et al. NTera 2 Cells: A human cell line which displays characteristics expected of a human committed neuronal progenitor cell , 1993, Journal of neuroscience research.
[48] J. Trojanowski,et al. Neurons Derived from a Human Teratocarcinoma Cell Line Establish Molecular and Structural Polarity Following Transplantation into the Rodent Brain , 1993, Experimental Neurology.
[49] N C Dracopoli,et al. Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. , 1984, Laboratory investigation; a journal of technical methods and pathology.